At the 2021 ASH annual meeting, Zachary Jackson et al. employed single cell RNA sequencing (scRNA-seq) and protein surface marker profiling in serial CD19 CAR-T cell samples from patients with NHL [104]. The gene discussed is CD19; the disease is non-Hodgkin lymphoma.